BioWorld - Wednesday, January 28, 2026

BioWorld Science

Dec. 23, 2021

View Archived Issues

Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders

Read More

SOCS1 is a major intracellular negative checkpoint of adoptive T-cell responses

Read More

Human mAbs prove a safe alternative to tetanus Ig for tetanus prevention and treatment in mice

Read More

Novel pleuromutilin derivatives with promising anti-MRSA activity

Read More

LAIR-1-targeting antibody NC-525 potentially effective against AML

Read More

Biomimetic synthesis of compounds from naturally abundant arglabin

Read More

SL-010110 inhibits gluconeogenesis and improves glucose homeostasis in diabetic mice

Read More

Topspin Therapeutics patents TMPRSS2 inhibitors

Read More

Autobahn Therapeutics divulges new thyromimetic compounds

Read More

Gilead Sciences identifies new LPAR1 antagonists

Read More

KSQ Therapeutics synthesizes USP1 inhibitors

Read More

Yumanity Therapeutics discloses PIKfyve inhibitors

Read More

Broader look reveals more contributions to chemotherapy damage

Read More

BiondVax signs agreements with Max Planck and UMG for COVID-19 NanoAbs

Read More

Novel aztreonam conjugates with promising activity against Gram-negative bacteria

Read More

Researchers present exosome-mediated system delivery of therapeutic cargo for HIV-1 repression

Read More

Claritas to develop R-107 for persistent pulmonary hypertension of the newborn

Read More

LogicBio nominates development candidate for treatment of hereditary tyrosinemia type 1

Read More